Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep 27;2(2):e000291.
doi: 10.1136/rmdopen-2016-000291. eCollection 2016.

Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies

Affiliations
Review

Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies

Thomas Schwartz et al. RMD Open. .

Abstract

Idiopathic inflammatory myopathies (IIM) include the main subgroups polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM) and juvenile DM (JDM). The mentioned subgroups are characterised by inflammation of skeletal muscles leading to muscle weakness and other organs can also be affected as well. Even though clinically significant heart involvement is uncommon, heart disease is one of the major causes of death in IIM. Recent studies show an increased prevalence of traditional cardiovascular risk factors in JDM and DM/PM, which need attention. The risk of developing atherosclerotic coronary artery disease is increased twofold to fourfold in DM/PM. New and improved diagnostic methods have in recent studies in PM/DM and JDM demonstrated a high prevalence of subclinical cardiac involvement, especially diastolic dysfunction. Interactions between proinflammatory cytokines and traditional risk factors might contribute to the pathogenesis of cardiac dysfunction. Heart involvement could also be related to myocarditis and/or myocardial fibrosis, leading to arrhythmias and congestive heart failure, demonstrated both in adult and juvenile IIM. Also, reduced heart rate variability (a known risk factor for cardiac morbidity and mortality) has been shown in long-standing JDM. Until more information is available, patients with IIM should follow the same recommendations for cardiovascular risk stratification and prevention as for the corresponding general population, but be aware that statins might worsen muscle symptoms mimicking myositis relapse. On the basis of recent studies, we recommend a low threshold for cardiac workup and follow-up in patients with IIM.

Keywords: Atherosclerosis; Cardiovascular Disease; Dermatomyositis; Polymyositis; Treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Traditional cardiovascular risk factors can cause cardiac disease in patients with IIM. Systemic and local inflammation may either have a direct effect on the myocardium or make the heart more susceptible to traditional risk factors. In the heart, disease can occur in the pericardium, coronary arteries or the myocardium, and arrhythmias can appear. Myocardial disease can result in diastolic or systolic dysfunction, and when clinical symptoms arise, the patient has developed heart failure. Myocardial disease may result in arrhythmias, or they can occur as a result of inflammation directly influencing cardiomyocyte function. Both arrhythmias and coronary artery disease, such as myocardial infarction, can directly result in heart failure.

References

    1. Solomon DH, Goodson NJ, Katz JN et al. . Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006;65:1608–12. 10.1136/ard.2005.050377 - DOI - PMC - PubMed
    1. Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011;7:399–408. 10.1038/nrrheum.2011.75 - DOI - PubMed
    1. Badui E, Garcia-Rubi D, Robles E et al. . Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985;36:431–41. 10.1177/000331978503600705 - DOI - PubMed
    1. Zöller B, Li X, Sundquist J et al. . Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS ONE 2012;7:e33442 10.1371/journal.pone.0033442 - DOI - PMC - PubMed
    1. Zöller B, Li X, Sundquist J et al. . Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol 2012;12:41 10.1186/1471-2377-12-41 - DOI - PMC - PubMed

LinkOut - more resources